Epidemiology and Outcomes of Retroperitoneal Sarcoma: An Analysis of the Population‐Based Cancer Registry in Japan 2016–2019
Journal of Surgical Oncology · 2025
DOI: 10.1002/jso.70074 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2025. Verfasst von Toshiyuki Takemori und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Sarcoma, Registries, Retroperitoneal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: This study was funded by the National Cancer Center Research and Development Funds (31-A-14, 2022-A-15)..
Abstract (Originalsprache)
Background
Retroperitoneal sarcoma (RPS) is a rare cancer, so few reports have previously characterized its national profiles. The capture rate of RPS in the Bone and Soft Tissue Tumor Registry was only 20%. The present study aimed to clarify the characteristics and clinical outcomes of RPS using the National Cancer Registry (NCR), which contains nationwide population‐based data from Japan.
Methods
We analyzed data from 20,079 patients with soft‐tissue sarcomas (STS), entered into the NCR in 2016–2019 using the International Classification of Diseases‐Oncology, Third Edition cancer topography and morphology codes. We extracted demographics (sex, age), tumor details (tumor location, histology, extent of disease), treatment, and prognosis for each patient.
Results
Of the 20,079 patients, 3311 patients were diagnosed with RPS. RPS accounts for 16.5% of all STS, with an adjusted incidence of 0.41/100,000/year. Of patients with RPS, 70.9% were aged 60 years or older and 52.7% were at the ‘regional’ stage at the time of diagnosis. Surgery was performed in 70.0% of cases, while chemotherapy and radiotherapy were performed in only 21.5% and 8.3% of cases, respectively. The 3‐year overall survival (OAS) of the RPS patients was 57.3%. The multivariate analyses showed that of the 3,311 patients with RPS, worse OAS was associated with being male, older age, a histology of undifferentiated pleomorphic sarcoma/malignant fibrous histiocytoma, cancer discovery other than by cancer/health screening, being treated at low‐volume hospitals, advanced disease, and not having surgery.
Conclusions
The present study is the first to have clarified the epidemiology, clinical features, treatment, prognosis, and significant factors affecting prognosis of patients with RPS in Japan. Level of Evidence Level Ⅲ, prognostic studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan.
- Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
- Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Chiba, Japan.
- Department of Public Health and Health Policy, The University of Tokyo, Tokyo, Japan.
ORCID-Profile: Toshiyuki Takemori, Shintaro Iwata, Shudai Muramatsu
Förderung
- This study was funded by the National Cancer Center Research and Development Funds (31-A-14, 2022-A-15).
Zitieren
APA
Takemori, T., Ogura, K., Morizane, C., Satake, T., Iwata, S., Toda, Y., Muramatsu, S., Kondo, H., Kobayashi, E., Higashi, T., & Kawai, A. (2025). Epidemiology and Outcomes of Retroperitoneal Sarcoma: An Analysis of the Population‐Based Cancer Registry in Japan 2016–2019. Journal of Surgical Oncology. https://doi.org/10.1002/jso.70074
Vancouver
Takemori T, Ogura K, Morizane C, Satake T, Iwata S, Toda Y, et al. Epidemiology and Outcomes of Retroperitoneal Sarcoma: An Analysis of the Population‐Based Cancer Registry in Japan 2016–2019. Journal of Surgical Oncology. 2025. doi:10.1002/jso.70074
BibTeX
@article{Takemori2025,
author = {Takemori, Toshiyuki and Ogura, Koichi and Morizane, Chigusa and Satake, Tomoyuki and Iwata, Shintaro and Toda, Yu and Muramatsu, Shudai and Kondo, Hiroya and Kobayashi, Eisuke and Higashi, Takahiro and Kawai, Akira},
title = {Epidemiology and Outcomes of Retroperitoneal Sarcoma: An Analysis of the Population‐Based Cancer Registry in Japan 2016–2019},
journal = {Journal of Surgical Oncology},
year = {2025},
doi = {10.1002/jso.70074}
}
EUVIMED